I migliori medici per il trattamento di Adenocarcinoma - TOP-21 medici

La Dr.ssa Pelles Sharon è specializzata in trattamenti avanzati per adenocarcinoma presso il Centro Medico Sourasky, inclusi HIPEC e immunoterapia.

• Esperta in Chemioterapia Intraperitoneale Ipertermica (HIPEC) per tumori addominali
• Fornisce protocolli di immunoterapia personalizzati, includendo Keytruda
• Svolge ricerche cliniche sugli atteggiamenti dei pazienti verso le sperimentazioni oncologiche
• Esegue complesse procedure di Whipple per adenocarcinoma pancreatico

Capo dell'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center – il dottor Merimsky è specializzato in casi complessi di sarcoma.

• Oltre 25 anni di esperienza in oncologia ortopedica
• Formazione in fellowship presso l'Institut Gustave Roussy di Parigi
• Membro della Facoltà di Sarcoma di ESMO e di IASLC
• Ha pubblicato numerosi articoli sulle neoplasie delle ossa e dei tessuti molli

Il Dr. Sarid è specializzato in chemioterapia e radioterapia con oltre 25 anni di esperienza in oncologia presso il principale Centro Medico Sourasky (Ichilov) di Israele.

• Formazione presso l'Università di Oxford in urologia oncologica
• Investigatore principale per studi clinici su terapie contro il cancro
• Autore di oltre 30 articoli sul trattamento del cancro
• Membro di ESMO, ASCO e delle società oncologiche israeliane

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Il Professor Ido Wolf dirige il dipartimento di oncologia medica presso il rinomato Sourasky Medical Center di Tel Aviv e offre consulenze per secondi pareri.

• Specializzato nella fornitura di secondi pareri in consulenze mediche
• Formazione approfondita presso Sheba Medical Center e Cedars-Sinai Medical Center
• Possiede un dottorato di ricerca e un ruolo accademico di insegnamento presso l'Università di Tel Aviv
• Iscritto a ASCO, AACR e altre importanti organizzazioni internazionali di oncologia

Il Dott. Raphael guida l'iniziativa nazionale israeliana di medicina genomica per l'oncologia e fa da pioniere nelle sperimentazioni cliniche sull'immunoterapia per il NSCLC.

• Docente senior presso la Facoltà di Scienze Mediche dell'Università di Tel Aviv
• Ricercatore principale per molteplici trial sull'immunoterapia per il NSCLC
• Moderatore del Molecular Tumor Board della Società Israeliana per il Cancro del Polmone
• Specializzato in profilazione genomica e tecniche di biopsia liquida
• Destinatario delle affiliazioni ESMO e IASLC

Il dottore si è laureato all'Università di Grodno, Bielorussia, e ha ottenuto la licenza medica in Israele nel 2000. Specializzandosi in medicina interna e oncologia, il dottore ha completato tirocini nel 10° Dipartimento di Medicina Interna e Oncologia presso il Centro Medico di Tel Aviv, Ichilov. Dal 2015, il dottore è direttore del reparto di ospedalizzazione oncologica nello stesso centro.<\/p>

Con una vasta esperienza come ricercatore primario e secondario, il dottore ha partecipato a studi clinici di prima, seconda e terza fase in oncologia, contribuendo significativamente al campo.<\/p>

Il medico è un chirurgo addominale specializzato in procedure sia aperte che minimamente invasive, inclusa la chirurgia di Whipple. Con oltre 20 anni di esperienza, il medico guida il Dipartimento di Chirurgia Colorettale al Sourasky Medical Center, dimostrando competenza nelle tecniche chirurgiche avanzate e nella cura del paziente.<\/p>

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Il medico è uno specialista in radioterapia e oncologo altamente qualificato con vasta esperienza nel trattamento di vari tipi di cancro. Specializzandosi in tecniche avanzate di radioterapia, il medico ha contribuito significativamente a migliorare i risultati dei pazienti attraverso piani di trattamento innovativi. Il medico è accreditato da importanti consigli medici e ha pubblicato numerosi articoli di ricerca in prestigiose riviste mediche, arricchendo il campo dell'oncologia con scoperte rivoluzionarie.<\/p>

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Il medico è un radioterapista altamente esperto, specializzato in tecniche avanzate di terapia radiante per il trattamento del cancro. Con oltre 15 anni di pratica, ha contribuito in modo significativo al campo attraverso la ricerca e le sperimentazioni cliniche, con l'obiettivo di migliorare i risultati dei pazienti. Il medico è stato riconosciuto per la sua esperienza in radiochirurgia stereotassica e terapia radiante modulata in intensità, fornendo cure all'avanguardia ai pazienti. Ha pubblicato numerosi articoli sottoposti a revisione paritaria ed è un frequente relatore in conferenze internazionali di oncologia.<\/p>

Il medico è un oncologo altamente esperto con un focus sul trattamento e la gestione del cancro. Con anni di pratica dedicata, il medico ha contribuito in modo significativo ai progressi in oncologia, implementando terapie all'avanguardia e partecipando a ricerche volte a migliorare i risultati dei pazienti. Il medico è riconosciuto per la sua leadership all'interno della comunità oncologica, avendo ricoperto ruoli chiave che guidano l'innovazione e la cura di qualità nel trattamento del cancro. La loro esperienza clinica è completata da un impegno per la cura centrata sul paziente e lo sviluppo professionale continuo.<\/p>